Financials
Value Q2, 25Q3, 25 TTM Selling/general/admin expenses 31.46 M33.22 M — Research & development 15.03 M17.3 M — Operating income -13.71 M-15.1 M — Non-Operating Income, Total 746 K2.07 M — Interest expense, net of interest capitalized 6.62 M3.45 M — Non-Operating Income, excl. Interest Expenses -5.76 M-1.04 M — Unusual income/expense -111 K-341 K — Pretax income -9.14 M-50.83 M — Equity in earnings —— — Taxes 59 K30 K — Non-controlling/minority interest —— — After tax other income/expense —— — Net income before discontinued operations -9.2 M-50.85 M — Discontinued operations —— — Net income -9.2 M-50.85 M — Dilution adjustment —— — Preferred dividends —— — Diluted net income available to common stockholders 9.2 M50.85 M — Basic earnings per share (Basic EPS) -1.46-1.04 — Diluted earnings per share (Diluted EPS) -1.46-1.04 — Average basic shares outstanding 6.24 M20.69 M — Diluted shares outstanding 6.24 M20.69 M — EBITDA —— — EBIT -13.71 M-15.1 M — Cost of revenue 10.65 M10.86 M — Other cost of goods sold —— — Depreciation & amortization (cash flow) —— —